Search results for "Atrial fibrillation"
MKSAP quiz on atrial fibrillation
This month's quiz includes questions from ACP's Medical Knowledge Self-Assessment Program (MKSAP 18) on atrial fibrillation.
https://acphospitalist.acponline.org/archives/2019/08/mksap-quiz-on-atrial-fibrillation.htm
15 Aug 2019
About 10% of home hospitalizations for HF require escalation of care
Median length of home hospital stay more than doubled when patients who were hospitalized at home for acute decompensated heart failure (HF) required transfer to an ED or medical inpatient unit, a retrospective study found.
https://acphospitalist.acponline.org/archives/2023/12/13/about-10percent-of-home-hospitalizations-for-hf-require-escalation-of-care.htm
13 Dec 2023
Off-label dosing of DOACs at discharge common in afib patients
More than 10% of patients hospitalized with afib receive a direct-acting oral anticoagulant (DOAC) at less or more than the recommended dose at discharge, according to data from the Get With The Guidelines-Atrial Fibrillation registry.
https://acphospitalist.acponline.org/archives/2023/11/15/off-label-dosing-of-doacs-at-discharge-common-in-afib-patients.htm
15 Nov 2023
Troponin level may help predict mortality in patients admitted with afib
Troponin levels were associated with risk for death, and coronary angiography was associated with both higher troponin levels and lower mortality.
https://acphospitalist.acponline.org/weekly/archives/2020/04/01/6.htm
1 Apr 2020
Studies estimate risks of bleeding, death in patients with cancer and atrial fibrillation
One recent study compared the predictive value of the HAS-BLED, ATRIA, and ORBIT scores in patients with cancer and afib, while another looked at clot, bleeding, and mortality risk with warfarin versus a direct-acting oral anticoagulant in patients with both conditions.
https://acphospitalist.acponline.org/archives/2022/12/07/studies-estimate-risks-of-bleeding-death-in-patients-with-cancer-and-atrial-fibrillation.htm
7 Dec 2022
Early anticoagulation appears safe after acute ischemic stroke in patients with afib
The AREST trial, which ended early due to changes in national guidelines, found statistically similar but numerically lower rates of the primary study outcome (fatal stroke, recurrent ischemic stroke, or transient ischemic attack) in those who received anticoagulation early with apixaban versus later with warfarin.
https://acphospitalist.acponline.org/weekly/archives/2021/03/03/5.htm
3 Mar 2021
1 in 3 adults with new-onset a fib during hospitalization have recurrence within a year
The findings suggest that patients who experience a transient episode of atrial fibrillation during hospitalization need risk stratification and follow-up, according to the authors of the matched cohort study.
https://acphospitalist.acponline.org/archives/2023/10/04/1-in-3-adults-with-new-onset-a-fib-during-hospitalization-have-recurrence-within-a-year.htm
4 Oct 2023
Test Yourself: MKSAP quiz on atrial fibrillation
These cases and commentary, which address atrial fibrillation, are excerpted from ACP's Medical Knowledge Self-Assessment Program (MKSAP15).
https://acphospitalist.acponline.org/archives/2012/08/ty.htm
15 Aug 2012
New COVID-19 boosters, biosimilar for MS OK’ed
The FDA approved updated COVID-19 vaccines and the first-ever biosimilar for multiple sclerosis (MS), among other recent actions.
https://acphospitalist.acponline.org/archives/2023/10/04/new-covid-19-boosters-biosimilar-for-ms-oked.htm
4 Oct 2023
Review finds 18% mortality in severe DOAC-related bleeding treated with reversal agent
A systematic review looked at 60 studies that evaluated four-factor prothrombin complex concentrates, idarucizumab, or andexanet for the treatment of severe or uncontrolled bleeding in patients on a direct oral anticoagulant (DOAC).
https://acphospitalist.acponline.org/weekly/archives/2021/06/16/4.htm
16 Jun 2021